Document is current
Any future updates will be listed below
-
Authors
Li, Qian
Liu, Sumei
Zheng, Tianqi
Li, Mo
Qi, Boling
Zhou, Liping
Liu, Bochao
Ma, Dan
Zhao, Chao
Chen, Zhiguo http://orcid.org/0000-0003-1508-510X
-
Funding
Funding for this research was provided by:
Stem Cell and Translation National Key Project (2016YFA0101403)
National Natural Science Foundation of China (82171250, 81973351)
Beijing Municipal Natural Science Foundation (5142005)
Beijing Talents Foundation (2017000021223TD03)
Support Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five–year Plan (CIT, TCD20180333)
Beijing Municipal Health Commission Fund (PXM2020_026283_000005)
Beijing One Hundred, Thousand, and Ten Thousand Talents Fund (2018A03)
Royal Society-Newton Advanced Fellowship (NA150482)
National Science Foundation for Young Scientists of China (31900740)
- License Information
-
More Information
Article History
Received: 19 May 2023
Accepted: 29 January 2024
First Online: 7 February 2024
Declarations
:
: Animal protocols were approved by the Laboratory Animal Ethics Committee of Xuanwu Hospital Capital Medicine University. All animal experiments were performed in accordance with the Chinese Ministry of Public Health Guide and the US National Institutes of Health Guide for the care and use of laboratory animals. All experimental procedures were approved and performed in accordance with the standards of the Experimental Animal Center of Xuanwu Hospital Capital Medical University. Title of the approved project: Cell therapy for Central Nervous System diseases. Approval number: XW-20210423-2. Date of approval: April 23, 2021.
: Not applicable.
: The authors declare that they have no conflict of interest.
